tofacitinib and Multiple-Myeloma

tofacitinib has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for tofacitinib and Multiple-Myeloma

Article	Year
Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica, 2018, Volume: 103, Issue:7 Topics: Animals; Bone Marrow; Cell Communication; Disease Models, Animal; Drug Repositioning; Humans; Janus Kinases; Mesenchymal Stem Cells; Mice; Multiple Myeloma; Phosphoproteins; Piperidines; Plasma Cells; Protein Kinase Inhibitors; Proteome; Proteomics; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors; Tumor Microenvironment; Xenograft Model Antitumor Assays	2018

Article

Year

Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.

Haematologica, 2018, Volume: 103, Issue:7

Topics: Animals; Bone Marrow; Cell Communication; Disease Models, Animal; Drug Repositioning; Humans; Janus Kinases; Mesenchymal Stem Cells; Mice; Multiple Myeloma; Phosphoproteins; Piperidines; Plasma Cells; Protein Kinase Inhibitors; Proteome; Proteomics; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018